angiodynamics.com (ANGO): Operatsion rentabellik

AngioDynamics Corp (ANGO) - korporativ logo

AngioDynamics, Inc. (ANGO) narxlar bosimini oldini olish uchun arzon sarf materiallaridan voz kechmoqda. Ushbu marjani kengaytirish strategiyasi saratonni davolash uchun NanoKnife AI tizimlarining joriy etilishi bilan bog'liq. Buyuk Britaniya va AQShdagi ishlab chiqarish quvvatlari asbob-uskunalarning uzluksiz ishlab chiqarilishini ta'minlaydi. Operatsion rentabellik tarixi foyda dinamikasini aniq ko'rsatadi va -6.00 ushbu ko'rsatkichning so'nggi qiymatini aks ettiradi.

ANGO - AngioDynamics Operatsion foyda koeffitsiyenti 04.07.2022 - 19.11.2026 oraligʻida

angiodynamics.com (ANGO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning umumiy tahlili:AngioDynamics Inc, ANGO
AngioDynamics, Inc. tayyor mahsulotlari

AngioDynamics, Inc. (ANGO) kompaniyasining operatsion marjasi moliyaviy xarajatlar va soliqlarni hisobga olguncha tibbiy tizimlarning ishlab chiqarish samaradorligini aks ettiradi. Ushbu ko'rsatkich umumiy savdoga nisbatan asosiy operatsiyalardan olingan foyda ulushini o'lchaydi, bu esa daromadlilikni baholash uchun juda muhimdir. Daromadning foiz ko'rsatkichi sifatida joriy operatsion foyda -6.00 miqdorida belgilanmoqda. Ushbu ko'rsatkichning tendentsiyasi biznesning ta'minot zanjiri uzilishlariga va maqsadli bozorlardagi sanksiyalar bilan bog'liq cheklovlarga nisbatan zaifligini ochib beradi. Marjaning barqarorligi kompaniyaning geosiyosiy zarbalarga nisbatan fundamental chidamliligini tasdiqlaydi.

AngioDynamics, Inc. (ANGO) raqobatchilari

ISRG (intuitive.com) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi DHR (Danaher Corp.)|Sotuvning operatsion marjasi BDX (Becton, Dickinson and Company)|Operatsion foyda koeffitsiyenti STE|Operatsion rentabellik West Pharma WST|Operatsion faoliyat rentabelligi Baxter (BAX)|MASI - Operatsion rentabellik|Operatsion faoliyat rentabelligi Stevanato Group Corp STVN|TFX: Operatsion marja|Sotuvning operatsion marjasi Merit Medical Systems|Operatsion rentabellik Envista Holdings Corp|Sotuvning operatsion marjasi ICU Medical Corp (ICUI)|Operatsion rentabellik DENTSPLY SIRONA Inc. (XRAY)|Sotuvning operatsion marjasi LeMaitre LMAT|Operatsion marja ATRC (atricure.com)|Operatsion marja staar.com STAA|NAGE - Operatsion rentabellik|Operatsion faoliyat rentabelligi ZimVie ZIMV|CERS (Cerus Corp) - Sotuvning operatsion marjasi|Alpha Teknova, Inc. - Operatsion foyda normasi|MGRM (Monogram Orthopedics Inc.) - Operatsion marja|STSS: Operatsion foyda normasi|Sotuvning operatsion marjasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja KRMD (korumedical.com)|Operatsion faoliyat rentabelligi Nyxoah, S.A. (NYXH)|MBOT - Operatsion rentabellik|PDEX (Pro-Dex, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|ZTEK (Zentek Ltd) - Sotuvning operatsion marjasi|ELUT - Operatsion faoliyat rentabelligi|MLSS (Milestone Scientific Corporation) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi NXGL (NEXGEL, Inc.)|Operatsion marja RVP|Sotuvning operatsion marjasi Harvard Bioscience HBIO|Operatsion marja FEMY (Femasys Corporation)|MHUA - Sotuvning operatsion marjasi|POAI - Operatsion rentabellik|Callan JMB (CJMB) - Sotuvning operatsion marjasi|ATRI: Operatsion marja|NURO - Operatsion faoliyat rentabelligi